A Deprescribing Initiative to Reduce Risk of Hypoglycemia in Long-Term Care Residents
March 1, 2022
JAMDA
Polypharmacy in long-term care (LTC) facilities is an ongoing concern. To address this issue, the Drive to Deprescribe (D2D) initiative targets reduction of antihyperglycemic agents to improve quality of life and reduce risk of hypoglycemia.